Clinical Trials
VerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the EFS with unprecedented yields
EVerZom, a biopharmaceutical company developing exosome based biodrugs, announces that it has reached a key milestone in its development with the production of a first exosome GMP batch in a 10L bioreactor with unprecedented yields. Regulatory validation of the technology was carried out in GMP clean rooms of...
Clinical Trials
New Endometrial Cancer Therapy Phase-II Trial Shows Promise
The most recent trial of a new antibody drug that goes on to deliver potent chemotherapy that too directly to the cancer cells for patients with advanced or recurrent endometrial cancer has gone a notch up to be studied...
Clinical Trials
Duality Looks Out For Hong Kong IPO To Finance ADC Trials
Duality Biotherapeutics from China has gone ahead and filed paperwork as far as a Hong Kong IPO is concerned, thereby looking out for an undisclosed sum so as to power a broad pipeline when it comes to antibody conjugates...
Clinical Trials
PhotonPharma Secures $2.5 Million in Seed Funding to Advance Clinical Trial for Ovarian Cancer Treatment
PhotonPharma, a cutting-edge biopharmaceutical company based in Fort Collins, Colorado, is pleased to announce the successful closing of a $2.5 million seed financing round. This vital funding will support the Phase I clinical trial of Innocell™, an innovative therapy...
Clinical Trials
Biotechs Recursion, Exscientia Merge For $850M And 10 Trials
The resultant biotech, which the businesses announced on Thursday, would have a pipeline that may produce 10 clinical readouts over the next 18 months, with a combined cash of $850 million.
According to a statement made on Thursday, the AI-enabled...
Clinical Trials
Key Factors In Clinical Trial Management And Cost Control
Running a clinical study entails significant costs and necessitates collaboration among sponsors, vendors, CROs, and sites to ensure trial success.
At the 13th Annual Clinical Trials in Oncology East Coast 2024 conference in Burlington, Massachusetts, panelists discussed the factors influencing...
Clinical Trials
Clinical Trial Supplies Market To Reach $3.72 Bn In 2028
The market for clinical trial supplies has shown strong growth recently, expanding from $2.52 billion in 2023 to $2.75 billion in 2024, with a compound annual growth rate (CAGR) of 8.9%. This growth in the historical period is attributed...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read